Bill Text: CA AB1645 | 2023-2024 | Regular Session | Enrolled
Bill Title: Health care coverage: cost sharing.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Vetoed) 2024-01-29 - Consideration of Governor's veto stricken from file. [AB1645 Detail]
Download: California-2023-AB1645-Enrolled.html
|
Enrolled
September 18, 2023 |
|
Passed
IN
Senate
September 12, 2023 |
|
Passed
IN
Assembly
September 13, 2023 |
|
Amended
IN
Senate
July 13, 2023 |
|
Amended
IN
Senate
July 03, 2023 |
|
Amended
IN
Assembly
May 01, 2023 |
|
Amended
IN
Assembly
March 20, 2023 |
CALIFORNIA LEGISLATURE—
2023–2024 REGULAR SESSION
Assembly Bill
No. 1645
| Introduced by Assembly Member Zbur |
February 17, 2023 |
An act to amend Section 1367.002 of, and to add Section 1367.0021 to, the Health and Safety Code, and to amend Section 10112.2 of, and to add Section 10112.20 to, the Insurance Code, relating to health care coverage.
LEGISLATIVE COUNSEL'S DIGEST
AB 1645, Zbur.
Health care coverage: cost sharing.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires a group or individual nongrandfathered health care service plan contract or health insurance policy to provide coverage for, and prohibits a contract or policy from imposing cost-sharing requirements for, specified preventive care services and screenings.
This bill would prohibit a group or individual health care service plan contract or health insurance policy issued, amended, or renewed on or after January 1, 2024, from imposing a cost-sharing requirement for office visits for the above-described
preventive care services and screenings and for items or services that are integral to their provision. The bill would prohibit large group contracts and policies issued, amended, or renewed on or after January 1, 2024, and an individual or small group health care service plan contract or health insurance policy issued, amended, or renewed on or after January 1, 2025, from imposing a cost-sharing requirement, utilization review, or other specified limits on a recommended sexually transmitted infections screening, and from imposing a cost-sharing requirement for any items and services integral to a sexually transmitted infections screening, as specified. The bill would require a plan or insurer to directly reimburse a nonparticipating provider or facility of sexually transmitted infections
screening that meets specified criteria for screening tests and integral items and services rendered, as specified, and would prohibit a nonparticipating provider from billing or collecting a cost-sharing amount for a sexually transmitted infections screening from an enrollee or insured. Because a violation of the bill’s requirements by a health care service plan would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Digest Key
Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: YESBill Text
The people of the State of California do enact as follows:
SECTION 1.
Section 1367.002 of the Health and Safety Code is amended to read:1367.002.
(a) A group or individual health care service plan contract shall, at a minimum, provide coverage for, and shall not impose any cost-sharing requirements for, any of the following:(1) Evidence-based items or services that have in effect a rating of “A” or “B” in the recommendations of the United States Preventive Services Task Force, as periodically updated.
(2) Immunizations that have in effect a recommendation, as periodically updated, from the Advisory Committee on Immunization Practices of the federal Centers for Disease Control and Prevention with respect to the individual involved.
(3) With respect to infants, children, and adolescents, evidence-informed preventive care and screenings provided in the comprehensive guidelines, as periodically updated, supported by the United States Health Resources and Services Administration.
(4) With respect to women, those additional preventive care and screenings not described in paragraph (1) as provided for in comprehensive guidelines supported by the United States Health Resources and Services Administration for purposes of this
paragraph.
(5) For the purposes of this section:
(A) The current recommendations of the United States Preventive Services Task Force regarding breast cancer screening, mammography, and prevention shall be considered the most current, not including those issued in or around November 2009.
(B) A health care service plan contract issued, amended, or renewed on or after January 1, 2024, shall not impose any cost-sharing requirement for office visits that are associated with the provision of an item or service that is required by this subdivision, or for any items or services that are integral to the provision of an item or service that is required by this subdivision, regardless of whether the office visit or
integral item or service is billed, or tracked as individual encounter data, separately from an item or service that is required by this subdivision.
(i) “Integral item or service” means an item, service, prescription drug, device, or product, or nonprescription drug, device, or product, that is a current, generally accepted standard of care or clinical practice for the provision of an item or service that is required by this subdivision.
(ii) “Current, generally accepted standard of care or clinical practice” means standards of care and clinical practice that are generally accepted by health care providers practicing in relevant clinical specialties, such as family medicine, pediatrics, preventive medicine, infectious diseases, obstetrics and gynecology, and public health.
Valid, evidence-based sources establishing current, generally accepted standards of care and clinical practice include peer-reviewed scientific studies and medical literature, the most recently updated clinical practice guidelines and recommendations of nonprofit health care provider professional associations, specialty societies and federal government agencies, including the American College of Obstetricians and Gynecologists and the federal Centers for Disease Control and Prevention, and product labeling approved by the United States Food and Drug Administration.
(b) This section does not prohibit a health care service plan from doing either of the following:
(1) Providing coverage for preventive items or services in addition to those required by subdivision (a).
(2) Denying coverage for services that are not recommended by the United States Preventive Services Task Force, except as provided by subdivision (d).
(c) A health care service plan shall provide coverage pursuant to subdivision (a) for plan years that begin on or after the date that is one year after the date that a novel recommendation or guideline is issued. A health care service plan shall provide coverage for modified or upgraded recommendations or guidelines pursuant to subdivision (a) no later than the first day of the plan year after the modification or upgrade was adopted or 90 days after the date on which the modification or upgrade was adopted, whichever is earlier in the calendar year.
(1) A health care service
plan that is required to provide coverage for any items and services specified in a recommendation or guideline described in subdivision (a) on the first day of a plan year shall provide coverage through the last day of the plan year, even if the recommendation or guideline changes or is no longer described in subdivision (a) during the plan year.
(2) Notwithstanding paragraph (1), if a recommendation or guideline described in paragraph (1) of subdivision (a) that was in effect on the first day of a plan year is downgraded to a “D” rating, or if any item or service associated with any recommendation or guideline specified in subdivision (a) is subject to a safety recall or is otherwise determined to pose a significant safety concern by a federal agency authorized to regulate the item or service during a plan year, a health care service plan
is not required to cover the item or service through the last day of the plan year.
(d) (1) A health care service plan contract shall cover items and services pursuant to this section in accordance with any applicable requirement of this chapter, including, but not limited to, Sections 1342.74 on prophylaxis of HIV infection, 1367.0021 on sexually transmitted infections screening, 1367.34 as added by Section 3 of Chapter 486 of the Statutes of 2021 on home test kits for sexually transmitted diseases, and 1367.668 on colorectal cancer screening.
(2) Notwithstanding paragraph (1),
Section 1367.25 shall exclusively govern the coverage of contraceptive drugs, devices, and products pursuant to this chapter.
(e) This section does not apply to a health care service plan contract that is a grandfathered health plan, or to a specialized health care service plan that does not cover an essential health benefit, as defined in Section 1367.005. The cost-sharing requirements of this section shall only apply to a health savings account-eligible health care service plan to the extent it does not fail to be treated as a high deductible health plan under Section 223 of Title 26 of the United States Code.
(f) The department shall coordinate with the Department of Insurance if it adopts regulations to implement this section.
SEC. 2.
Section 1367.0021 is added to the Health and Safety Code, to read:1367.0021.
(a) In addition to the items and services that are required by Section 1367.002, a large group health care service plan contract issued, amended, or renewed on or after January 1, 2024, or an individual or small group contract issued, amended, or renewed on or after January 1, 2025, shall not impose a cost-sharing requirement on a sexually transmitted infections screening that is recommended by the federal Centers for Disease Control and Prevention (CDC) in the most recently updated version of its Sexually Transmitted Infections Treatment Guidelines or as most recently recommended by the CDC in the Morbidity and Mortality Weekly Report or similar method of official public communication. If a screening recommendation of the United States Preventive Services Task Force conflicts with that of the CDC, or omits a CDC screening recommendation, a health care service plan contract shall not require any cost sharing for a sexually transmitted infections screening, or for any items and services that are integral to a screening, that is performed by an essential community provider or participating provider, facility, or processing laboratory consistent with the CDC’s recommendation.(b) Notwithstanding Section 2713 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-13), a health care service plan contract issued, amended, or renewed on or after January 1, 2024, shall not require or impose any of the following for coverage of sexually transmitted infections screening, or of any items and services that are integral to a screening, that is performed by an essential community provider or participating provider, facility, or processing laboratory:
(1) Prior authorization or other utilization review requirements.
(2) Limits on frequency, method, treatment, or setting.
(3) Limits on confirmatory or post-treatment retesting of an asymptomatic patient.
(4) Limits that are based on risk of infection, sexual behavior, sexual orientation, gender, or anatomical sites of screening.
(5) Any other limits on the coverage or provision of sexually transmitted infections screening as a preventive item or service under this section, Section 1367.002, or Section 1367.34 as added by Section 3 of Chapter 486 of the Statutes of 2021, as a preventive basic health care service, or that constitutes a discriminatory benefit design
or marketing practice, as prohibited by this chapter.
(c) A large group health care service plan contract issued, amended, or renewed on or after January 1, 2024, or an individual or small group contract issued, amended, or renewed on or after January 1, 2025, shall not impose a cost-sharing requirement for sexually transmitted infections screening, or for any items and services that are integral to a screening, under this section, Section 1367.002, or Section 1367.34 as added by Section 3 of Chapter 486 of the Statutes of 2021, regardless of any of the following:
(1) The location of sample collection or
processing, including at locations that are both clinical and nonclinical in nature, regardless of whether a location constitutes a health care setting.
(2) The screening test, testing method or algorithm, or method of sample collection or processing.
(3) The identity or qualifications of the individual who collected or processed a sample.
(4) The clinical circumstances of screening, including whether or not a screening was based on risk of infection, or there was an emergent or urgent need for immediate or prompt screening or the results of screening.
(d) (1) A health care service plan shall directly reimburse a nonparticipating
provider or facility of sexually transmitted infections screening for screening tests and integral items and services rendered, if the provider or facility was an essential community provider when the screening tests and integral items and services were rendered. If a nonparticipating essential community provider does not generate the results of screening, the provider shall submit the samples to a participating processing laboratory. A nonparticipating essential community provider shall not bill or collect any cost-sharing amounts from an enrollee for a sexually transmitted infections screening, or for integral items and services, under this section, Section 1367.002, or Section 1367.34 as added by Section 3 of Chapter 486 of the Statutes of 2021.
(2) For items and services rendered subject to this section, unless otherwise agreed to
by a nonparticipating essential community
provider and the health care service plan, the plan shall reimburse an essential community provider the greater of its average contracted rate or 125 percent of the amount Medicare reimburses on a fee-for-service basis for the same or similar items or services in the general geographic region in which the items or services were rendered.
(e) For purposes of this section:
(1) “Average contracted rate” means the average of the contracted commercial rates paid by the health care service plan for the same or similar items or services in the geographic region.
(2) “Essential community provider” means a provider or facility that is eligible for listing, and is listed, on the California Health Benefit Exchange’s
Essential Community Provider List.
(3) “General geographic region” has the same meaning as provided by Section 1371.31 and the regulations promulgated thereunder.
(4) “Gender” means sex, including gender identity and gender expression.
(5) “Gender expression” means gender-related appearance and behavior, whether or not stereotypically associated with assigned sex at birth.
(6) “Utilization review” has the same meaning as defined by Section 1374.721 and any regulations promulgated thereunder.
(f) This section does not apply to a specialized health care service plan contract that does not cover an
essential health benefit, as defined by Section 1367.005. If a health care service plan contract is a high deductible health plan under the definition set forth in Section 223(c)(2) of Title 26 of the United States Code, the contract shall not impose a deductible on sexually transmitted infections screening, or on integral items and services, under this section, Section 1367.002, or Section 1367.34 as added by Section 3 of Chapter 486 of the Statutes of 2021, unless not applying the deductible would conflict with federal requirements for high deductible health plans.
(g) The delayed implementation of subdivisions (a) and (c) for individual and small group health care service plan contracts does not excuse compliance with Section 1367.002. An individual or small group health care service
plan contract issued, amended, or renewed on or after January 1, 2024, shall comply with the coverage and cost-sharing requirements for sexually transmitted infections screening under Section 1367.002.
SEC. 3.
Section 10112.2 of the Insurance Code is amended to read:10112.2.
(a) A group or individual health insurance policy shall, at a minimum, provide coverage for, and shall not impose any cost-sharing requirements for, any of the following:(1) Evidence-based items or services that have in effect a rating of “A” or “B” in the recommendations of the United States Preventive Services Task Force, as periodically updated.
(2) Immunizations that have in effect a recommendation, as periodically updated, from the Advisory Committee on Immunization Practices of the federal Centers for Disease Control and Prevention with respect to the individual involved.
(3) With respect to infants, children, and adolescents, evidence-informed preventive care and screenings provided in the comprehensive guidelines, as periodically updated, supported by the United States Health Resources and Services Administration.
(4) With respect to women, those additional preventive care and screenings not described in paragraph (1) as provided for in comprehensive guidelines supported by the United States Health Resources and Services Administration for purposes of this paragraph.
(5) For the purposes of this section:
(A) The current recommendations of the United States Preventive Services Task Force regarding breast cancer screening, mammography, and prevention shall be considered the
most current, not including those issued in or around November 2009.
(B) A health insurance policy issued, amended, or renewed on or after January 1, 2024, shall not impose any cost-sharing
requirement for office visits that are associated with the provision of an item or service that is required by this subdivision, or for any items or services that are integral to the provision of an item or service that is required by this subdivision, regardless of whether the office visit or integral item or service is billed, or tracked as individual encounter data, separately from an item or service that is required by this subdivision.
(i) “Integral item or service” means an item, service, prescription drug, device, or product, or nonprescription drug, device, or product, that is a current, generally accepted standard of care or clinical practice for the provision of an item or service that is required by this subdivision.
(ii) “Current, generally accepted
standard of care or clinical practice” means standards of care and clinical practice that are generally accepted by health care providers practicing in relevant clinical specialties, such as family medicine, pediatrics, preventive medicine, infectious diseases, obstetrics and gynecology, and public health. Valid, evidence-based sources establishing current, generally accepted standards of care and clinical practice include peer-reviewed scientific studies and medical literature, the most recently updated clinical practice guidelines and recommendations of nonprofit health care provider professional associations, specialty societies and federal government agencies, including the American College of Obstetricians and Gynecologists and the federal Centers for Disease Control and Prevention, and product labeling approved by the United States Food and Drug Administration.
(b) This section does not prohibit a health insurer from doing either of the following:
(1) Providing coverage for services in addition to those required by subdivision (a).
(2) Denying coverage for services that are not recommended by the United States Preventive Services Task Force, except as provided by subdivision (d).
(c) A health insurer shall provide coverage pursuant to subdivision (a) for policy years that begin on or after the date that is one year after the date that a novel recommendation or guideline is issued. A health insurer shall provide coverage for modified or upgraded recommendations or guidelines pursuant to subdivision (a) no later
than the first day of the plan year after the modification or upgrade was adopted or 90 days after the date on which the modification or upgrade was adopted, whichever is earlier in the calendar year.
(1) A health insurer that is required to provide coverage for any items and services specified in a recommendation or guideline described in subdivision (a) on the first day of a policy year shall provide coverage through the last day of the policy year, even if the recommendation or guideline changes or is no longer described in subdivision (a) during the policy year.
(2) Notwithstanding paragraph (1), if a recommendation or guideline described in paragraph (1) of subdivision (a) that was in effect on the first day of a policy year is downgraded to a “D” rating, or if any item
or service associated with any recommendation or guideline specified in subdivision (a) is subject to a safety recall or is otherwise determined to pose a significant safety concern by a federal agency authorized to regulate the item or service during a policy year, a health insurer is not required to cover the item or service through the last day of the policy year.
(d) (1) A health insurance policy shall cover items and services pursuant to this section in accordance with any applicable requirement of this part, including, but not limited to, Sections 10112.20 on sexually transmitted infections screening, 10123.1933 on prophylaxis of HIV infection,
10123.207 on colorectal cancer screening, and 10123.208 on home test kits for sexually transmitted diseases.
(2) Notwithstanding paragraph (1), Section 10123.196 shall exclusively govern the coverage of contraceptive drugs, devices, and products pursuant to this part.
(e) This section does not apply to a health insurance policy that is a grandfathered health plan, or to a specialized health insurance policy that does not cover an essential health benefit, as defined in Section 10112.27. The cost-sharing requirements of this section shall only apply to a health savings account-eligible health insurance policy to the extent it does not fail to be treated as a high deductible health plan under Section 223 of Title 26 of the United States Code.
(f) The department shall coordinate with the Department of Managed Health Care if it adopts regulations to implement this section.
(g) The commissioner and department may exercise the authority provided by this code and the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340), Chapter 4.5 (commencing with Section 11400), and Chapter 5 (commencing with Section 11500) of Part 1 of Division 3 of Title 2 of the Government Code) to implement and enforce this section and all related sections, including those referenced herein. If the commissioner assesses a civil penalty for a violation, any hearing that is requested by the insurer shall be conducted by an administrative law judge of the Administrative Hearing Bureau of the department under the formal
procedure of Chapter 5. This subdivision does not impair or restrict the commissioner’s authority pursuant to another provision of this code or the Administrative Procedure Act.
SEC. 4.
Section 10112.20 is added to the Insurance Code, immediately following Section 10112.2, to read:10112.20.
(a) In addition to the items and services that are required by Section 10112.2, a large group health insurance policy or policy subject to Section 10965.03 issued, amended, or renewed on or after January 1, 2024, or an individual or small group policy issued, amended, or renewed on or after January 1, 2025, shall not impose a cost-sharing requirement on a sexually transmitted infections screening that is recommended by the federal Centers for Disease Control and Prevention (CDC) in the most recently updated version of its Sexually Transmitted Infections Treatment Guidelines or as most recently recommended by the CDC in the Morbidity and Mortality Weekly Report or similar method of official public communication. If a screening recommendation of the United States Preventive Services Task Force conflicts with that of the CDC, or omits a CDC screening recommendation, a health insurance policy shall not require any cost sharing for a sexually transmitted infections screening, or for any items and services that are integral to a screening, that is performed by an essential community provider or participating provider, facility, or processing laboratory consistent with the CDC’s recommendation.(b) Notwithstanding Section 2713 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-13), a health insurance policy issued, amended, or renewed on or after January 1, 2024, shall not require or impose any of the following for coverage of
sexually transmitted infections screening, or of any items and services that are integral to a screening, that is performed by an essential community provider or participating provider, facility, or processing laboratory:
(1) Prior authorization or other utilization review requirements.
(2) Limits on frequency, method, treatment, or setting.
(3) Limits on confirmatory or post-treatment retesting of an asymptomatic patient.
(4) Limits that are based on risk of infection, sexual behavior, sexual orientation, gender, or anatomical sites of screening.
(5) Any other limits on the coverage or provision
of sexually transmitted infections screening as a preventive item or service under this section, Section 10112.2, or Section 10123.208, as a preventive basic health care service, or that constitutes a discriminatory benefit design or marketing practice as prohibited by this chapter.
(c) A large group health insurance policy or policy subject to Section 10965.03 issued, amended, or renewed on or after January 1, 2024, or an individual or small group policy issued, amended, or renewed on or after January 1, 2025, shall not impose a cost-sharing requirement for sexually
transmitted infections screening, or for any items and services that are integral to a screening, under this section, Section 10112.2, or Section 10123.208, regardless of any of the following:
(1) The location of sample collection or processing, including at locations that are both clinical and nonclinical in nature, regardless of whether a location constitutes a health care setting.
(2) The screening test, testing method or algorithm, or method of sample collection or processing.
(3) The identity or qualifications of the individual who collected or processed a sample.
(4) The clinical circumstances of screening, including whether or not a screening was based
on risk of infection, or there was an emergent or urgent need for immediate or prompt screening or the results of screening.
(d) (1) A health insurer shall directly reimburse a nonparticipating provider or facility of sexually transmitted infections screening for screening tests and integral items and services rendered, if the provider or facility was an essential community provider when the screening tests and integral items and services were rendered. If a nonparticipating essential community provider does not generate the results of screening, the provider shall submit the samples to a participating processing laboratory. A nonparticipating essential community provider shall not bill or collect any cost-sharing amounts from an insured for a sexually transmitted infections screening, or for integral items and
services, under this section, Section 10112.2, or Section 10123.208.
(2) For items and services rendered subject to this section, unless otherwise agreed to by a nonparticipating essential community provider and the health insurer, the insurer shall reimburse an essential community provider the greater of its average contracted rate or 125 percent of the amount Medicare reimburses on a fee-for-service basis for the same or similar items or services in the general geographic region in which the items or services were rendered.
(e) For purposes of this section:
(1) “Average contracted rate” means the average of the contracted commercial rates paid by the health insurer for the same or similar items or services in the
geographic region.
(2) “Essential community provider” means a provider or facility that is eligible for listing, and is listed, on the California Health Benefit Exchange’s Essential Community Provider List.
(3) “General geographic region” has the same meaning as provided by Section 10112.82 and the regulations promulgated thereunder.
(4) “Gender” has the same meaning as in Section 10140 and any regulations promulgated thereunder.
(5) “Gender expression” has the same meaning as in Section 10140 and any regulations promulgated thereunder.
(6) “Utilization review” has the same meaning as defined by Section
10144.52 and any regulations promulgated thereunder.
(f) This section does not apply to a specialized health insurance policy that does not cover an essential health benefit, as defined by Section 10112.27. If a health insurance policy is a high deductible health plan under the definition set forth in Section 223(c)(2) of Title 26 of the United States Code, the policy shall not impose a deductible on sexually transmitted infections screening, or on integral items and services, under this section, Section 10112.2, or Section 10123.208, unless not applying the deductible would conflict with federal requirements for high deductible health plans.
(g) The delayed implementation of subdivisions (a) and (c) with respect to
individual and small group health insurance policies does not excuse a health insurer from complying with Section 10112.2. An individual or small group health insurance policy issued, amended, or renewed on or after January 1, 2024, shall comply with the coverage and cost-sharing requirements for sexually transmitted infections screening under Section 10112.2.
